                         SEQUENCE LISTING - RULE 13ter

<110>  HARRIS, Adrian L.
       LIU, Stanley K.
       MUSCHEL, Ruth
 
<120>  Methods of Enhancing the Response to Radiation in Tumor Therapy 
       Using Anti-DLL4 Antibodies

<130>  11406-13-304

<150>  61/498,200
<151>  2011-06-17

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  5
<212>  PRT
<213>  DLL4-binding fragment - Heavy Chain CDR1

<400>  1

Asn Tyr Gly Ile Thr 
1               5   


<210>  2
<211>  17
<212>  PRT
<213>  DLL4-binding fragment - Heavy Chain CDR2

<400>  2

Trp Ile Ser Ala Tyr Asn Gly Asn Thr Asn Tyr Ala Gln Lys Leu Gln 
1               5                   10                  15      


Asp 
    


<210>  3
<211>  15
<212>  PRT
<213>  DLL4-binding fragment - Heavy Chain CDR3

<400>  3

Asp Arg Val Pro Arg Ile Pro Val Thr Thr Glu Ala Phe Asp Ile 
1               5                   10                  15  


<210>  4
<211>  13
<212>  PRT
<213>  DLL4-binding fragment - Light Chain CDR1

<400>  4

Ser Gly Ser Ser Ser Asn Ile Gly Ser Tyr Phe Val Tyr 
1               5                   10              


<210>  5
<211>  7
<212>  PRT
<213>  DLL4-binding fragment - Light Chain CDR2

<400>  5

Arg Asn Asn Gln Arg Pro Ser 
1               5           


<210>  6
<211>  12
<212>  PRT
<213>  DLL4-binding fragment - Light Chain CDR3

<400>  6

Ala Ala Trp Asp Asp Ser Leu Ser Gly His Trp Val 
1               5                   10          


<210>  7
<211>  60
<212>  PRT
<213>  DLL4-binding fragment - Heavy Chain Polypeptide

<400>  7

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Tyr 
            20                  25                  30          


Gly Ile Thr Trp Val Arg Gln Ala Pro Gly Gln Gly Pro Ala Phe Asp 
        35                  40                  45              


Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
    50                  55                  60  


<210>  8
<211>  111
<212>  PRT
<213>  DLL4-binding fragment - Light Chain Polypeptide

<400>  8

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Ser Tyr 
            20                  25                  30          


Phe Val Tyr Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Arg Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Glu Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Arg 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ala Trp Asp Asp Ser Leu 
                85                  90                  95      


Ser Gly His Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


